Bristol-Myers Squibb Co. (BMYMP)
Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Other Report or Announcement
ONON Investors Have Opportunity to Join On Holding AG Fraud Investigation with the Schall Law Firm
Events and transactions
Other Report or Announcement
Notice of special meeting for 4.5.26 - proxy voting form and more
Prospectus, shelf prospectus, shelf offering report
Events and transactions
Events and transactions
Events and transactions